Stephen Shiao, MD
Enriched profileProfessor and Director (Division of Basic Science Research) · Cedars-Sinai Medical Center
Stephen Shiao is Professor and Director (Division of Basic Science Research) at Cedars-Sinai Medical Center. OpenAlex indexes 227 publications with 7,256 citations (h-index 39); ClinicalTrials.gov lists 10 registered studies with this person as an investigator.
Data verified 28 Oct 2026
Overview
Updated 28 Oct 2026
Stephen Shiao, MD, is Professor and Director (Division of Basic Science Research) at Cedars-Sinai Medical Center. The public record shows 227 publications with 7,256 citations (h-index 39), centered on Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies, Immunotherapy and Immune Responses. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 1 companies.
- Most recent indexed publication: 2026 · Cancer research
- Top research focus: Cancer Immunotherapy and Biomarkers
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 72.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 28 Oct 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
Sponsor: Cedars-Sinai Medical Center
Industry payments
Updated 28 Oct 2026
1 company reported payments to CMS in program years 2022–2022. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20221 payment
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 28 Oct 2026
67 congress contributions (2006–2026) across AACR, ASCO, ASTRO per OpenAlex. The most recent:
- Abstract 6610: Gut microbiome modulation shapes tumor responses to radiation in oral cavity carcinoma.
AACR Annual Meeting
AACR2026Co-author - Abstract B014: Divergent treatment responses in genetically distinct EGFR-mutant models of glioblastoma
AACR Annual Meeting
AACR2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 28 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Chronic antigen in solid tumors drives a distinct program of T cell residence.
Science immunology
Article2023
Most-cited works
by citation count (OpenAlex)- 01Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to ChemotherapyArticle1,714 citations2011
- 02Immune microenvironments in solid tumors: new targets for therapyPreprint322 citations2011
- 03
- 04Metastatic Lymph Node Burden and Survival in Oral Cavity CancerArticle300 citations2017
- 05Commensal bacteria and fungi differentially regulate tumor responses to radiation therapyArticle277 citations2021
Network
Updated 28 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 28 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/stephen-shiao-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
amportal.astro.org/stephen-shiao-md-phd-35231871
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →amportal.astro.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 28 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
PhD
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →am25.astro.org ↗ - MD
PhD, Yale University School of Medicine (Department of Immunobiology)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedevents.com ↗ - Radiation Oncology residency
University of California, San Francisco
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedevents.com ↗
Editorial & leadership roles
journal and society appointments- Vice-Chair
ASTRO Scientific Review Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →am25.astro.org ↗ - Barth Family Chair in Cancer Research (endowed chair)
Cedars-Sinai Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →am25.astro.org ↗ - Co-Leader
Experimental Therapeutic Program, Cedars-Sinai Cancer Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →am25.astro.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Raj Makkar, MD
Cedars-Sinai Medical Center
Eduardo Marban, MD
Cedars-Sinai Medical Center
Stephen Freedland, MD
Cedars-Sinai Medical Center
Cristina Ferrone, MD
Cedars-Sinai Medical Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Eric Winer, MD
Yale School of Medicine
Norman Wolmark, MD
University of Pittsburgh
Hope Rugo, MD
City of Hope